Aktis Oncology, Inc. (AKTS)

Typically moves ±7.01% on earnings
EARNINGS ANALYTICS
search

Aktis Oncology, Inc. (AKTS) has only 3 recorded earnings events on file, so its post-earnings track record is limited. Its biggest recorded post-earnings gain was +8.16% (Mar 30, 2026) and its biggest decline was +4.74% (Aug 13, 2026).

Earnings reactions

How AKTS moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

3

Avg Abs. Movement

±7.01%

Positive %

100.0%

Negative %

0.0%

Historical Earnings Statistics

Date Timing Earnings move SEC Filing
Aug 13, 2026 ☽ POST +4.74% open_in_new
May 11, 2026 ☽ POST +8.13% open_in_new
Mar 30, 2026 ☽ POST +8.16% open_in_new
event

Earnings Count

3

Total earnings in dataset

trending_up

Avg Abs. Movement

±7.01%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 21 →
21
Funds holding
$171437561
Total value held
Buying
18 added · 2 reduced
Blackrock, Inc.
$73431479 +7.87%
Merck & Co., Inc.
$30710162 Held
Janus Henderson Group Plc
$26022437 NEW BUY
State Street Corp
$15599642 +13.02%
Northern Trust Corp
$5819933 +20.81%

Frequently asked about AKTS earnings

How much does AKTS stock move after earnings? expand_more

Over 3 reports, AKTS has moved an average of ±7.01% the session after earnings, closing higher 100.0% of the time.

What was AKTS's biggest post-earnings move? expand_more

AKTS's largest post-earnings gain on record was +8.16% on Mar 30, 2026, and its largest decline was +4.74% on Aug 13, 2026.

Where can I find Aktis Oncology, Inc.'s SEC filings? expand_more

All of Aktis Oncology, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.